Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II/III, Randomised, Two-Arm, Comparison of Maintenance Lapatinib Versus Placebo After First-Line Chemotherapy in Patients With HER1 and/or HER2 Overexpressing Locally Advanced or Metastatic Bladder Cancer [LaMB]

NCT00949455 is registered in ClinicalTrials.gov with Queen Mary University of London as lead sponsor.

NCT NCT00949455
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00949455 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II/III, Randomised, Two-Arm, Comparison of Maintenance Lapatinib Versus Placebo After First-Line Chemotherapy in Patients With HER1 and/or HER2 Overexpressing Locally Advanced or Metastatic Bladder Cancer [LaMB]
Lead sponsor
Queen Mary University of London
Phase
Phase 2/3
Overall status
Unknown status
Start date
March 31, 2009
Completion date
Not reported
Enrollment
204 (estimated)
Sites
27

Conditions

As the registry lists them; a condition with its own page is linked.

bladder cancer